BEAM compared with AMGN: revenue, margins and what each company keeps, and the suppliers and customers both name

BEAMBeam Therapeutics Inc.

Mkt capRevenueRevenue

AMGNAmgen Inc

Mkt capRevenueRevenue

Compare

BEAMBeam Therapeutics Inc.

AMGNAmgen Inc

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Supply-chain overlap

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Supply-chain overlap

direct ties · both sidesSources ›

direct ties · both sides

Only BEAM 9

LLYEli Lillycustomer

PFEPfizercustomer

SANASana Biotechnologycustomer

PRMEPrime Medicinesupplier

5 more · BEAM chain ›

Shared 0

No shared counterparties.

Only AMGN 12

PODDInsuletsupplier

CYTKCytokineticssupplier

ARWRArrowhead Pharmaceuticalssupplier

LGNDLigand Pharmaceuticalssupplier

Role chip = supplier or customer—= no ticker (unlisted)Source: SEC EDGAR

8 more · AMGN chain ›

BEAMBeam Therapeutics Inc.

25.85▼−6.97%

Mkt cap$2.9BRevenue$307,000Q3 FY26Revenue$140MFY25

AMGNAmgen Inc

463.60▼−3.11%

Regular sessionNov 5 '26

Mkt cap$258.8BRevenue$10.4BQ3 FY26Revenue$36.8BFY25

Compare

Regular sessionNov 5 '26

BEAMBeam Therapeutics Inc.

AMGNAmgen Inc

25.85▼−6.97%

Price

463.60▼−3.11%

$2.9B

Mkt cap

$258.8B

Q3 FY26$307,000

Revenue

$10.4BQ3 FY26

FY25$140M

Revenue

$36.8BFY25

BEAM25.85▼−6.97%vsAMGN463.60▼−3.11%Regular sessionNov 5 '26